Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma - Concepedia

Concepedia

Publication | Closed Access

Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma

97

Citations

25

References

2009

Year

Madeleine Duvic, Elise A. Olsen, Debra Breneman, Theresa Pacheco, Sareeta Parker, Eric C. Vonderheid, Rachel Abuav, Justin L. Ricker, Syed Rizvi, Cong Chen,

Clinical Lymphoma & Myeloma

Lymphoid NeoplasiaOncologyLong-term TolerabilityClinical BenefitDermatologyAdult T-cell Leukemia-lymphomaImmunotherapyMedicine

References

	Year	Citations

Page 1

Page 1